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Abstract 
Background: Giardia duodenalis is a gastrointestinal protozoan causing 184 million cases of giardiasis worldwide 
annually. Detection is by microscopy or coproantigen assays, although sensitivity is often compromised by intermit‑
tent shedding of cysts or trophozoites, or operator expertise. Therefore, for enhanced surveillance field‑applicable, 
point‑of‑care (POC), molecular assays are needed. Our aims were to: (i) optimise the recombinase polymerase ampli‑
fication (RPA) assay for the isothermal amplification of the G. duodenalis β‑giardin gene from trophozoites and cysts, 
using published primer and probes; and (ii) perform a pilot field validation of RPA at a field station in a resource‑poor 
setting, on DNA extracted from stool samples from schoolchildren in villages around Lake Albert, Uganda. Results 
were compared to an established laboratory small subunit ribosomal RNA (SSU rDNA) qPCR assay with additional test‑
ing using a qPCR targeting the triose phosphate isomerase (tpi) DNA regions that can distinguish G. duodenalis of two 
different assemblages (A and B), which are human‑specific.
Results: Initial optimisation resulted in the successful amplification of predicted RPA products from G. duodenalis‑
purified gDNA, producing a double‑labelled amplicon detected using lateral flow strips. In the field setting, of 129 
stool samples, 49 (37.9%) were positive using the Giardia/Cryptosporidium QuikChek coproantigen test; however, the 
RPA assay when conducted in the field was positive for a single stool sample. Subsequent molecular screening in the 
laboratory on a subset (n = 73) of the samples demonstrated better results with 21 (28.8%) RPA positive. The SSU rDNA 
qPCR assay resulted in 30/129 (23.3%) positive samples; 18 out of 73 (24.7%) were assemblage typed (9 assemblage 
A; 5 assemblage B; and 4 mixed A+B). Compared with the SSU rDNA qPCR, QuikChek was more sensitive than RPA 
(85.7 vs 61.9%), but with similar specificities (80.8 vs 84.6%). In comparison to QuikChek, RPA had 46.4% sensitivity and 
82.2% specificity.
Conclusions: To the best of our knowledge, this is the first in‑field and comparative laboratory validation of RPA for 
giardiasis in low resource settings. Further refinement and technology transfer, specifically in relation to stool sample 
preparation, will be needed to implement this assay in the field, which could assist better detection of asymptomatic 
Giardia infections.
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Background
Giardia duodenalis (syns G. lamblia and G. intesti-
nalis) is a flagellated protozoan parasite of the human 
gastrointestinal tract as well as a range of other mam-
mals worldwide. It is acquired by ingestion of viable 
cysts present in faecal-contaminated water, food or 
on fomites [1]. Ingested cysts undergo excystation 
into actively multiplying trophozoites in the duode-
num, which attach to the intestine causing epithelial 
inflammation, villous flattening and malabsorption. 
Symptoms include acute or chronic diarrhoea, weight 
loss and impaired development in children [1, 2]. The 
encysted stage is passed in stools [2]. Symptomatic 
giardiasis results in around 184 million clinical cases 
globally per year. Giardia duodenalis infection can be 
asymptomatic and undetected carriers remain a source 
of infection. On the basis of molecular characterisation, 
G. duodenalis is divided into eight genetic assemblages 
(A–H), of which A and B are considered human-specific 
[3]; thus, it is important to identify which assemblages 
are present during validation of any new molecular 
diagnostic based on species-specific DNA loci.
Detection of G. duodenalis is routinely carried out by 
identifying cysts or trophozoites in faeces using direct 
microscopy, with variable sensitivity and specificity. 
These methods can be labour-intensive, requiring mul-
tiple examinations or involve complicated concentration 
procedures best performed by experienced technicians 
[4, 5]. Immunological and molecular techniques have 
achieved better sensitivity of 79–100% [6] but specificity 
can be reduced. A drawback of molecular assays is often 
the need for expensive and sophisticated equipment that 
is not available in resource-poor endemic settings. Giar-
diasis is particularly common in Uganda [7]. Al-Shehri 
et al. [8] reported a prevalence of G. duodenalis infection 
at 42% (40/96) using the rapid QuikChek coproantigen 
test and 87% (221/254) by qPCR in Ugandan children 
(5–10 years-old), with many heavy infections.
Unlike conventional PCR-based methods, recombi-
nase polymerase amplification (RPA) is an isothermal 
amplification system that is rapid and requires only basic 
and portable equipment [9] making it feasible for the 
point-of-care (POC) diagnosis of tropical diseases in low 
resource endemic settings. Crannell et al. [10] developed 
an RPA assay for G. duodenalis amplifying a fragment of 
the β-giardin gene. Here, we further optimised this RPA 
assay for G. duodenalis for use in a resource-poor setting, 
and tested its applicability at a field station in a remote 
rural area near Lake Albert, Uganda, highly endemic for 
giardiasis. Additionally, we utilised the commercially 
available Giardia/Cryptosporidium QuikChek coproanti-
gen test (Abbott, Maidenhead, UK), in the field to inves-
tigate the prevalence of giardiasis in a cohort of children 
from the endemic area of Lake Albert. Samples from this 
cohort were also analysed using the small subunit ribo-
somal RNA gene (SSU rDNA) qPCR assay for Giardia 
and also the triose phosphate isomerase (tpi) qPCR assay 
to enable discrimination of assemblage A and B G. duo-
denalis [11]. RPA and the QuikChek coproantigen test 




Giardia duodenalis genomic DNA controls
Cryopreserved G. duodenalis trophozoite pellets, assem-
blage A (sourced from the London School Hygiene and 
Tropical Medicine (LSHTM), London, UK) and G. duo-
denalis cysts H-3 (human isolate, assemblage B; P101, 
Waterborne Inc., New Orleans, USA) were used as 
sources of control DNA for the testing of the RPA and 
qPCR assays. The control DNA samples were extracted 
using the QIAamp DNA Mini Kit (51304; Qiagen, Man-
chester, UK), with modifications: cells were mixed with 1 
ml of NucliSENS lysis buffer (supplied as containing 50% 
guanidine thiocyanate, < 2% Triton X-100, < 1% EDTA) 
(200292; BioMerieux, Basingstoke, UK) and Precellys Soil 
Mix beads SK38 (03961-1-006; Stretton Scientific, Stret-
ton, UK). Samples were vortexed for 5 min, and incu-
bated at room temperature for 20 min. Beads and debris 
were pelleted by centrifugation at 14,000× rpm for 2 min. 
Two hundred microliters of supernatant was transferred 
to a clean microcentrifuge tube and the manufacturer’s 
protocol for the Qiagen 51304 QIAamp DNA Mini Kit 
was followed thereafter, with the DNA being eluted in 
200 µl of AE buffer (10 mM Tris-Cl, 0.5 mM EDTA; pH 
9.0).
Recombinase polymerase amplification (RPA) and lateral 
flow G. duodenalis assay
All primer and probe sequences used were as previously 
described [10] (Additional file  1: Table  S1). Figure  1a 
depicts the binding locations on the RPA probes and 
primers for the β-giardin gene.
Three different areas in the laboratory were assigned 
for (i) the RPA master mix preparation, (ii) the addition 
of DNA, and (iii) the RPA reaction and lateral flow ampli-
con detection in a laminar flow hood. This was done to 
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prevent cross-contamination and false positives. Reac-
tions were performed using the TwistAmp nfo kit (TAN-
FO02KIT; TwistDx, Maidenhead, UK) in a final volume 
of 50 µl. The master mix consisted of 29.5 µl of rehy-
dration buffer, 2.1 µl of 10 µM forward primer, 2.1 µl of 
10 µM reverse primer, 0.6 µl of 10 µM probe, 7.5 µl of 
5 M betaine (720 mM) (B0300; Sigma-Aldrich, Gilling-
ham, UK) and 2.5 µl of  H2O. The RPA nfo pellets were 
transferred to sterile individually capped 0.2 ml tubes, 
to which 37.5 µl of master mix was added. Then, 2.5 µl 
of 280 mM magnesium acetate was added to the inside 
wall of each tube. Ten microlitres of extracted DNA was 
added to the tubes, which were then inverted manually 8 
to 10 times and centrifuged briefly. Negative controls (no 
template) were incorporated into each set of reactions.
Reactions were incubated at 37 °C for 30 min in a ther-
mal cycler (Applied Biosystems 9700). At minutes 4 and 
15 of the incubation, the tubes were removed from the 
cycler, inverted manually 8 to 10 times and then centri-
fuged briefly before being returned to 37 °C. After 30 min 
of incubation, the reactions were immediately placed at 
4 °C. Rapid detection of the FAM-biotin double-labelled 
amplification product was visualised using lateral flow 
Milenia Genline HybriDetect (MGHD) strips in a dipstick 
format and also the PCRD Nucleic Acid Detector lateral 
flow cassettes (Abingdon Health, York, UK). Detections 
using the MGHD strips were performed by adding 2 µl 
of the RPA reaction to 98 µl of supplied detection buffer, 
into which the strips were then placed; after 5 min of 
incubation at room temperature the results were assessed 
visually as positive or negative by the presence or absence 
of the test line. For the PCRD cassettes, the following 
manufacturer’s recommendations were used: 5 µl of the 
RPA reaction was added to 70 µl of the cassette running 
buffer; the whole 75 µl was then added to the PCRD cas-
sette window and incubated at room temperature for 10 
Fig. 1 RPA of the G. duodenalis β‑giardin gene. a RPA primers amplify nts 796–978 of GenBank X85958: binding sites of primers (clear boxes) and 
probe (shaded box) with modifications of the probe (5’ FAM, internal THF, 3’ block) and the reverse primer (5’ biotin); the reverse primer is depicted 
on the corresponding sequence of the sense strand. b Identification of predicted amplification products by gel electrophoresis. See Methods for 
the derivation of the two amplicons. c Presence of the double‑labelled RPA product detected visually on the lateral‑flow cassette from trophozoite 
and cyst DNA. Abbreviations: Mk, DNA size marker; nts, nucleotides; THF, tetrahydrofuran
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min. These assays were also assessed visually by the pres-
ence or absence of the test line.
Successful RPA reactions were also assessed by elec-
trophoresis of the reaction products. Amplicons were 
column-purified (28104: Qiagen) and then run on a 2% 
agarose gel to check for specific amplification of the 153 
bp amplicon, i.e. the double-labelled RPA product.
Field assessment at Lake Albert, Uganda
Stool collection
Single stool samples were collected from primary school 
children in three Ugandan villages on the shore of Lake 
Albert. Participant children were randomly selected from 
schools where studies of intestinal schistosomiasis were 
ongoing [12]. A field station laboratory was set up nearby 
at the Bugoigo research camp consisting of a small build-
ing with separate areas for DNA extraction from the 
stool samples, RPA preparation and amplicon detection. 
The field station was equipped with all the necessary 
resources for performing the stool DNA extractions and 
the RPA with electricity supplied by means of a portable 
generator. An aliquot of fresh stool (c.500 µl) was homog-
enized with PBS (1:1). A second aliquot of stool was pre-
pared by homogenizing 500 µl of fresh faeces with 500 µl 
of 70% ethanol, in a 2.0 ml screw-cap tube; these aliquots 
were stored for later testing as described below.
Coproantigen test
An aliquot of stool was also tested at the field station with 
the commercially available Giardia/Cryptosporidium 
QuikChek coproantigen test (Abbott), according to 
manufacturer’s instructions. Briefly, the stool sample was 
added to the supplied diluent/conjugate mixture, trans-
ferred to the test cassette containing anti-Giardia mono-
clonal antibodies, and after addition of the supplied wash 
buffer and substrate, results were read visually.
Field stool DNA extraction for RPA
DNA was extracted from each stool sample homogenized 
in PBS using the QIAamp DNA Mini Kit (51304; Qia-
gen). Approximately 200 mg of the stool samples were 
transferred to a 2 ml screw-cap tube containing 1 ml of 
the NucliSENS lysis buffer and Precellys Soil Mix beads 
SK38. Samples were vortexed for 5 min, and incubated 
at room temperature for 20 min. Beads and debris were 
collected in a pellet by centrifugation at 14,000× rpm for 
2 min. Two hundred microliters of the supernatant was 
transferred to a clean microcentrifuge tube and the man-
ufacturer’s protocol was followed thereafter. DNA was 
eluted in 200 µl of AE buffer.
Field RPA analysis
RPA assays were performed in the field using the assay 
conditions as described above, except that 0.7 µl of 5 M 
betaine (70 mM) was added for each reaction. Amplifi-
cation was carried out at 37 °C using a dry block heater 
(SP2280; SciQuip, Wem, UK). Detection of amplicons 
was performed using PCRD Nucleic Acid Detector lat-
eral flow cassettes as described above.
Subsequent laboratory testing of the field samples 
at LSHTM
Stool DNA extraction
Stool samples that had been stored in ethanol were 
washed 3 times with PBS and then extracted using the 
QIAamp DNA Stool Mini Kit (51504; Qiagen) following 
the manufacturer’s protocol, and eluted in 200 µl of sup-
plied buffer AE. The DNA concentration was determined 
using a Nanodrop ND-1000 spectrophotometer (Thermo 
Fisher Scientific, Paisley, UK). The use of this kit, an 
alternative to the QIAamp DNA Mini Kit used in the 
original Giardia RPA assay published by Crannell et  al. 
[10] and in this work at the Lake Albert field station, was 
employed here to remove potential inhibitors from the 
samples for downstream molecular assays. These assays 
were: RPA (as detailed above); assemblage-specific qPCR 
(tpi gene); and non-assemblage specific SSU qPCR test.
Assemblage‑specific qPCR assays
The assemblage-specific multiplex qPCR [11] was per-
formed on individual samples. Primers and probes are 
listed in Additional file 1: Table S1 and binding sites are 
shown in Additional file 2: Figure S1. Each reaction was 
performed in a total volume of 20 µl, and comprised 10 
µl of 2× reaction mix (B20.23-01; PCR Biosystems, Lon-
don, UK), 0.8 µl of a 10 µM solution of each forward and 
reverse primer for assemblage A and B, 0.4 µl of a 10 µM 
solution of each assemblage (A and B) probe, 4.4 µl of 
DNA, and 1.6 µl of  ddH2O. Samples were run on a Rotor-
Gene 3000 machine (Corbett Research, Mortlake, Aus-
tralia) using the following cycling conditions: 1 cycle at 
95 °C for 2 mins; 40 cycles at 95 °C for 5 s and 60 °C for 30 
s. Each qPCR run included positive controls containing 
DNA extracted from trophozoite (assemblage A) and cyst 
(assemblage B). Thresholds to calculate Cq values were 
set compared to water controls in each run. Negative (no 
template) reactions were run with each set of reactions.
SSU rDNA qPCR
The SSU rDNA qPCR was performed on the same DNA 
extracts as described above using the primer and probe 
sequences as previously described [13, 14]. The primers 
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and probe are listed in Additional file:1: Table  S1 and 
binding sites are shown in Additional file  2: Figure S1. 
Reactions were performed in a total volume of 20 μl, and 
comprised 10 µl of 2× reaction mix (B20.23-01; PCR Bio-
systems), 0.8 µl of a 10 µM solution of each primer, 0.4 
µl of a 10 µM solution of probe, 5 µl of DNA, and 3 µl 
of  ddH2O. Samples were run on a Rotor-Gene 3000 as 
described above.
Statistical tests
Confidence intervals (95% CI) for sensitivity and specific-
ity comparisons of SSU rDNA qPCR, RPA and QuikChek 
were calculated using Graphpad QuickCalcs (https ://
www.graph pad.com/quick calcs /ConfI nterv al1.cfm).
Receiver operating characteristic (ROC) curves for 
comparing RPA and the QuikChek coproantigen test 
against the SSU rDNA qPCR as the ‘gold standard’ were 
calculated using easyRoc v1.3.1 (http://www.bioso ft.hacet 




As shown in Fig. 1b, the RPA with DNA extracted from 
the G. duodenalis cultures generated amplicons of the 
predicted sizes from the β-giardin gene. The 153-bp 
FAM-biotin double-labelled product could be reliably 
identified by the PCRD lateral flow cassette; cyst DNA 
diluted to  104 (approximately 6 ng/µl) generated RPA 
products detectable by lateral flow and confirmed by gel 
electrophoresis (Fig.  1c). As predicted from the binding 
sites of the RPA primers and probe (Fig. 1a), two ampli-
cons were produced: the 153-bp double-labelled ampli-
con produced by the RPA probe with primer RPA LF 
REV; and the 183-bp amplicon produced by primers RPA 
FOR and RPA LF REV. As described by Piepenburg et al. 
[9] the RPA probe binds the 183-bp amplicon, allowing 
nfo endonuclease to expose a 3’-OH, and Bsu polymer-
ase to generate the 153-bp double-labelled amplicon. 
We observed, during our initial optimisation phase that 
the MGHD strips were prone to producing false-positive 
results from water (no template) controls, and thus were 
not well suited for field application, so the use of those 
strips was discontinued and the PCRD cassettes were uti-
lised. Another crucial modification during the optimisa-
tion was the addition of betaine into the RPA reaction 
mix, following determination of optimal concentration 
via titration. This reagent was used to prevent the forma-
tion of false-positive products generated in no-template 
controls due to secondary structure formation by the 
primers and probe.
Assays performed at the field station
The location and lakeshore environment of Bugoigo are 
shown Fig.  2a. The equipment used at the field station 
laboratory (including a microcentrifuge for spin-column 
DNA extraction and a dry heating block for isothermal 
incubation of RPA reactions) functioned reliably, allow-
ing a total of 129 collected stool samples to be assayed. 
RPA gave positive results using control DNA from puri-
fied trophozoites, and also a single stool sample extracted 
in the field (Fig.  2b). However, the remaining samples 
extracted and tested in the field were negative by RPA, 
with no false-positives observed. Forty-nine stool sam-
ples from the 129 examined (37.9%) were positive using 
the Giardia/Cryptosporidium QuikChek (Table 1).
Subsequent assays performed at LSHTM on the field 
samples extracted using the QIAamp DNA Stool Mini Kit
Of the 129 samples tested 30 (23.25%) were positive for 
G. duodenalis by SSU rDNA qPCR (Table  1). Due to 
resource limitations, only a subset of 73 samples could be 
assayed by RPA at LSHTM. Of these, 21 (28.8%, 95% CI: 
19.6–40.1%) were RPA-positive; 13 (17.8%, 95% CI: 10.6–
28.3%) were positive by both RPA and the SSU rDNA 
qPCR (Table 2); and 10 (13.7%, 95% CI: 7.4–23.6%) were 
positive by all three assays, QuikChek coproantigen, SSU 
rDNA qPCR and RPA.
Within this subset, considering the SSU rDNA qPCR 
(n = 21 positive) as the ‘gold standard’, the QuikChek 
coproantigen test (18/21; 85.7%, 95% CI: 64.5–95.8%) 
was more sensitive than RPA (13/21, 61.9%, 95% CI: 
40.1–79.3%), but with a similar specificity (80.8%, 95% CI: 
67.9–89.4% vs 84.6%, 95% CI: 72.2–92.2%, respectively) 
(Table 2). Compared to the QuikChek coproantigen test, 
RPA had a sensitivity of 46.4% (95% CI: 29.5–64.2%) and 
a specificity of 82.2% (95% CI: 68.4–90.1%) (Table 3). Fig-
ure 3 shows the corresponding ROC curves for the gold 
standard SSU rDNA qPCR. For RPA, the area under the 
curve (AUC) was 0.73 (95% CI: 0.62–0.85) (P = 0.0001) 
and for QuikChek the AUC was 0.83 (95% CI: 0.74–0.93) 
(P < 0.0001).
For the G. duodenalis assemblage A and B qPCR, 
from the subset of 73 samples tested, assemblage typing 
was performed for 18 (24.7%) of the samples and char-
acterised as: 9 samples as assemblage A; 5 samples as 
assemblage B; and 4 samples were of mixed assemblage 
infections for A and B.
Discussion
In this study we found the RPA assay, when tested in the 
laboratory at the LSHTM, to have 61.9% sensitivity and 
84.6% specificity, compared to the gold standard SSU 
rDNA qPCR for detecting G. duodenalis in faecal sam-
ples collected from school children in endemic villages 
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around Lake Albert, Uganda. We have demonstrated here 
that the RPA assay can be used to amplify and detect spe-
cific DNA regions of G. duodenalis within faecal extracts, 
and that the assay is transposable to field station facilities, 
albeit with scope for further development, specifically in 
relation to the sample preparation. Crannell et  al. [10] 
first developed the β-giardin RPA assay for G. duodenalis, 
which was assessed on spiked stool samples from healthy 
subjects and on samples from children in Peru, report-
ing 73% sensitivity against a gold standard of positivity 
Table 2 Results comparing QuikChek and RPA with SSU rDNA 
qPCR (n = 73)
SSU rDNA qPCR
Positive Negative
QuikChek Positive 18 10
Negative 3 42
RPA Positive 13 8
Negative 8 44
Table 3 Results comparing QuikChek and RPA (n = 73)
QuikChek
Positive Negative
RPA Positive 13 8
Negative 15 37
Fig. 2 Lake Albert field setting. a Map of Uganda showing the location of the Bugoigo field site and lakeshore environment. b RPA under field 
conditions gave positive results for control DNA from G. duodenalis trophozoites and a stool sample. Photo credit: A. Bustinduy. Map source: http://
www.simpl emapp r.net
Table 1 Results of field samples assayed by QuikChek and SSU 
rDNA qPCR for Giardia (n = 129)
Positive Negative
QuikChek 49 80
SSU qPCR 30 99
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DNA. However, we cannot discount the possibility that 
the use of betaine may have also decreased the sensitivity 
of the assay. The AUC values from ROC curve analysis 
are encouraging, with scope for further optimisation. A 
future development of the RPA approach applied here 
to Giardia DNA would be the use of real time fluores-
cent RPA assays (TwistAmp exo; TwistDx). This uses 
a fluorescent probe that can be detected during DNA 
amplification and reactions can be run in small port-
able temperature-controlled fluorescence readers. These 
assays have also been reported to be more sensitive, have 
a reduced risk of cross-contamination and are more 
straightforward to carry out [16]. However, sample prep-
aration is key for assay robustness and the need for the 
equipment needed for the extraction kits used reduces 
the field applicability of the RPA assay.
Giardia duodenalis subspecies assemblages A and B 
are considered to be human-specific [3]. Studies that 
have associated assemblage with clinical manifestations 
have not revealed a straightforward relationship, and 
there are conflicting reports from different settings of 
assemblages A or B being associated with diarrhoea and 
other symptoms [17]. The assemblage A- and B- spe-
cific qPCRs used here were first reported on giardiasis 
cases in the UK [11], with this same method later used 
on Ugandan [18] and Cambodian samples [19]. Assem-
blage typing from Ugandan human samples has reported 
assemblages A and B in single and mixed infections [18, 
20–23]. Additional file 3: Figure S2 maps the assemblage 
typing from human samples from the present study and 
from the five previous reports, which have used the tpi 
gene and other genetic targets. As seen in the previous 
studies, we detected both assemblages A and B circu-
lating in human populations in Uganda, and here in the 
Lake Albert environment. In addition to disease surveil-
lance, this RPA assay may also be applicable to monitor 
by qPCR or microscopy, but acknowledged that the assay 
required further improvement and validation under field 
conditions.
Of note, during the course of this study, we encoun-
tered several unexpected technical issues, relating to fae-
cal DNA extraction and subsequent RPA reaction and 
detection. Stool samples contain many inhibitors that are 
detrimental to molecular assays and it is crucial to reduce 
their presence as much as possible. Furthermore, faecal 
matter and Giardia cysts may require additional physical 
disruption to facilitate DNA extraction. The use of both 
the QIAamp DNA Mini Kit and QIAamp DNA Stool 
Mini Kit has been reported in the literature for stool 
Giardia DNA extraction. Initially during the RPA opti-
misation phase at LSHTM and at the Bugoigo field sta-
tion, we used the QIAamp DNA Mini Kit in a modified 
protocol that included preliminary steps employing soil 
mix beads and NucliSENS lysis buffer prior to standard 
extraction protocol. For better field applicability, the pos-
sible effects on DNA extraction of local temperature and 
humidity should be considered. However, as an alterna-
tive method, we later changed to the QIAamp DNA Stool 
Mini Kit which greatly increased the performance of the 
RPA assay.
Additionally, the combination of betaine in the reaction 
mix and the use of the PCRD cassettes for detection [15], 
rather than the MGHD strips reported previously for this 
Giardia RPA [10], greatly increased the reliability of the 
RPA technique in our hands. We found that in the initial 
laboratory optimisation, the RPA assays without betaine 
were susceptible to giving false positives, although this 
could be controlled by using a concentration of 720 mM 
betaine with purified culture DNA; however, as this may 
have suppressed weak positives from stool-extracted 
DNA, we found after serial titration of spiked stool that 
this could be decreased to 70 mM for stool-extracted 
Fig. 3 ROC curves of RPA and QuikChek against SSU rDNA qPCR
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therapeutic outcome of treatment and also to detection 
Giardia in faecal samples from infected animals.
Study limitations
There are some limitations of this study. Issues relating 
to the extraction of high-purity DNA from stool samples 
impeded the field validations and should be further inves-
tigated, including alternative, more streamlined, meth-
ods for DNA extraction, such as that used for RPA with 
bovine stool samples [24], with emphasis on standardisa-
tion for field application. The absolute limit of detection 
of stool-extracted Giardia DNA by the RPA used in the 
present study should be fully determined, particularly in 
relation to that for SSU rDNA qPCR. Additionally, vali-
dation is needed on a set of well-defined clinical samples 
containing other gastro-intestinal pathogens to evaluate 
assay specificity, although the RPA-amplified sequence is 
specific to G. duodenalis by NCBI BLAST search.
Conclusions
We have shown here that RPA can be applied successfully 
for the detection of Giardia DNA in field-collected stool 
samples for disease surveillance; however further optimi-
sation of sample preparation, particularly with regard to 
DNA extraction from stool samples are required to make 
this RPA more suitable as point-of-care test, prior to sub-
sequent field validations.
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